Charltons
  • The Firm
    • Overview
    • People and Culture
    • Experience and Approach
    • Our Approach
    • Diversity
    • Responsible Business
    • Careers
    • Awards
    • Locations
    • Team Profiles
    • Training, Knowledge, Culture
    • Global Reach
    • One Belt One Road
    • Why Choose Charltons
    • Work Life Balance
    • Career Path
    • How to Apply
    • Current Jobs
    Team Profiles

    Team Profiles

    Find out more
    Training, Knowledge, Culture

    Training, Knowledge, Culture

    Find out more
    Global Reach

    Global Reach

    Find out more
    One Belt One Road

    One Belt One Road

    Find out more
    Why Choose Charltons

    Why Choose Charltons

    Find out more
    Work Life Balance

    Work Life Balance

    Find out more
    Career Path

    Career Path

    Find out more
    How to Apply

    How to Apply

    Find out more
    Current Jobs

    Current Jobs

    Find out more
  • What We Do
    • Corporate Finance and Capital Markets
    • M&A
    • Regulatory, Securities and Derivatives
    • Corporate and Commercial
    • Private Equity and Funds
    • Private Wealth, Trusts and Family Offices
    • Services
    • Industries
    • Due Diligence
    • Public Takeovers in Hong Kong
    • Reverse Takeovers in Hong Kong
    • Private M&A
    • Cross Border M&A
    • Mineral Company M&A
    • China M&A
    • Hong Kong Securities Law
    • Hong Kong Listing Rules
    • Hong Kong Insurance Companies
    • PRC Securities Law
    • Company Law
    • Restructuring
    • Investment Funds: China & Offshore
    • Investment Funds: Hong Kong
    • Private Equity and Hedge Fund Investment
    • Family Offices in Hong Kong
    • Trusts in Hong Kong
    Industries

    Industries

    Find out more
    Due Diligence

    Due Diligence

    Find out more
    Public Takeovers in Hong Kong

    Public Takeovers in Hong Kong

    Find out more
    Reverse Takeovers in Hong Kong

    Reverse Takeovers in Hong Kong

    Find out more
    Private M&A

    Private M&A

    Find out more
    Cross Border M&A

    Cross Border M&A

    Find out more
    Mineral Company M&A

    Mineral Company M&A

    Find out more
    China M&A

    China M&A

    Find out more
    Hong Kong Securities Law

    Hong Kong Securities Law

    Find out more
    Hong Kong Listing Rules

    Hong Kong Listing Rules

    Find out more
    Hong Kong Insurance Companies

    Hong Kong Insurance Companies

    Find out more
    PRC Securities Law

    PRC Securities Law

    Find out more
    Company Law

    Company Law

    Find out more
    Restructuring

    Restructuring

    Find out more
    Investment Funds: China & Offshore

    Investment Funds: China & Offshore

    Find out more
    Investment Funds: Hong Kong

    Investment Funds: Hong Kong

    Find out more
    Private Equity and Hedge Fund Investment

    Private Equity and Hedge Fund Investment

    Find out more
    Family Offices in Hong Kong: Comprehensive Financial Services for High Net Worth Families

    Family Offices in Hong Kong: Comprehensive Financial Services for High Net Worth Families

    Find out more
    Trusts in Hong Kong: Establishing and Managing Trust Structures

    Trusts in Hong Kong: Establishing and Managing Trust Structures

    Find out more
  • Insights
    • IPOs
    • Green Bonds
    • Hong Kong Regulatory Compliance
    • Hong Kong Company Law
    • China
    • Publications and Presentations
    • Webinars and Podcasts
    • Hong Kong’s Market Statistics for 2020
    • Impact of HKEx Listing Reforms of 2018
  • Newsletters
    • Subscribe Now
    • Hong Kong Law
    • Updates
    • China Law
    • China News Alerts
    • Natural Resources
    • Archives
  • News and Events
  • Contact
    • Contact Us
    • Enquiry Form
  • The Firm
    • Overview
    • People and Culture
      • Team Profiles
      • Training, Knowledge, Culture
    • Experience and Approach
    • Our Approach
      • Global Reach
      • One Belt One Road
    • Diversity
    • Responsible Business
    • Careers
      • Why Choose Charltons
      • Work Life Balance
      • Career Path
      • How to Apply
      • Current Jobs
    • Awards
    • Locations
  • What We Do
    • Corporate Finance and Capital Markets
      • Services
      • Industries
    • M&A
      • Due Diligence
      • Public Takeovers in Hong Kong
      • Reverse Takeovers in Hong Kong
      • Private M&A
      • Cross Border M&A
      • Mineral Company M&A
      • China M&A
    • Regulatory, Securities and Derivatives
      • Hong Kong Securities Law
      • Hong Kong Listing Rules
      • Hong Kong Insurance Companies
      • PRC Securities Law
    • Corporate and Commercial
      • Company Law
      • Restructuring
    • Private Equity and Funds
      • Investment Funds: China & Offshore
      • Investment Funds: Hong Kong
      • Private Equity and Hedge Fund Investment
    • Private Wealth, Trusts and Family Offices
      • Family Offices in Hong Kong
      • Trusts in Hong Kong
  • Insights
    • IPOs
      • Hong Kong’s Market Statistics for 2020
      • Impact of HKEx Listing Reforms of 2018
    • Green Bonds
    • Hong Kong Regulatory Compliance
    • Hong Kong Company Law
    • China
    • Publications and Presentations
    • Webinars and Podcasts
  • Newsletters
    • Subscribe Now
    • Hong Kong Law
    • Updates
    • China Law
    • China News Alerts
    • Natural Resources
    • Archives
  • News and Events
  • Contact
    • Contact Us
    • Enquiry Form
  • 中文
    facebook linkedin instagram youtube Spotify for Creators - Charltons Law Podcasts rumble
    ©Copyright Charltons 2024. All rights reserved.
facebook linkedin instagram youtube Spotify for Creators rumble
中文
    Hong Kong Launches Dedicated Technology Enterprises Channel (TECH) for the listing of Specialist Technology Companies and Biotech Companies

    Hong Kong Launches Dedicated Technology Enterprises Channel (TECH) for the listing of Specialist Technology Companies and Biotech Companies

    Hong Kong Law
    03 Jun 2025
    Biotech Companies HKEX Specialist Technology

    The Securities and Futures Commission (SFC) and The Stock Exchange of Hong Kong Limited (HKEx) jointly announced the launch of the Technology Enterprises Channel (TECH) and a new confidential filing option in their Joint Announcement of 6 May 2025. According to the HKEx, these initiatives are designed to streamline the listing of Specialist Technology Companies and Biotech Companies on the HKEx’s Main Board under Chapters 18C and 18A, respectively, of the Rules Governing the Listing of Securities on the Main Board of the Hong Kong Stock Exchange (Main Board Listing Rules).

    Pre-Application Guidance through TECH

    The newly launched TECH aims to offer proactive, specialised guidance to prospective Specialist Technology Company and Biotech Company listing applicants seeking to list under Main Board Listing Rules Chapter 18C and Chapter 18A before they submit their listing applications. The Joint Announcement states that TECH aims to enhance prospective Specialist Technology Companies’ and Biotech Companies’ understanding of the Main Board Listing Rules and the listing application requirements through four core mechanisms. These are:

    • a specialised team to conduct a preliminary review of the listing application and provide specific guidance on the requirements of Main Board Listing Rules Chapter 18C or Chapter 18A, as appropriate;
    • engagement sessions to foster mutual understanding of the prospective companies’ business models and the Hong Kong regulatory requirements;
    • guidance and eligibility and suitability assessments for listing, including assistance on the requirements for Core Products, cross-jurisdictional Biotech Products and clinical trial acceptance; Sophisticated Investor qualifications; industries accepted as Specialist Technology Industries and the evaluation frameworks for assessing whether emerging industries that are not explicitly covered by the existing Main Board Listing Rules can qualify as Specialist Technology Companies; and
    • dedicated channels enabling case-specific consultations with the HKEx on Main Board Listing Rules interpretations.

    The HKEx encourages prospective Specialist Technology Companies and Biotech Companies to leverage this channel when applying to list in Hong Kong. To initiate contact, potential listing applicants need to submit a Technology Enterprises Channel (TECH) Enquiry Form, with the additional information required by Form-M119, by email to IPO_TECH@hkex.com.hk. Further guidance on listing Specialist Technology Companies and Biotech Companies is available in Chapter 2.5 of the Guide for New Listing Applicants and Chapter 2.3 of the Guide for New Listing Applicants, respectively.

    Confidential Filing Option

    As Specialist Technology Companies and Biotech Companies are often pre-revenue companies or at an early stage of their development, the HKEx and the SFC recognise their heightened vulnerability to harm from premature disclosure of their key operational strategies, proprietary technologies, and undisclosed listing plans. To mitigate these concerns, the HKEx – with the SFC’s formal consent under Main Board Listing Rule 2.04 – now permits confidential submission of Application Proofs for listing applications under Main Board Listing Rules Chapter 18C and Chapter 18A with immediate effect for listing applications filed after 6 May 2025. As set out in Chapter 6.4 of the Guide for New Listing Applicants, Main Board Listing Rules Chapter 18C and Chapter 18A listing applicants are generally not required to comply with the Application Proof publication requirements under Practice Note 22. These listing applicants are also not required to publish an Overall Coordinator Announcement (OC Announcement) at the time of filing the listing application but rather at the same time of publishing the Post Hearing Information Pack. Other requirements on the publication of the Application Proof and the OC Announcement are also outlined in Chapter 6.4 of the Guide for New Listing Applicants.

    Specialist Technology Companies and Biotech Companies with Weighted Voting Rights (WVR) Structures

    In parallel, the HKEx has updated Chapter 2.2 of its Guide for New Listing Applicants to simplify Weighted Voting Rights (WVR) requirements for Specialist Technology Companies and Biotech Companies. Main Board Listing Rules Chapter 18C and Chapter 18A already impose additional requirements on prospective listing applications to demonstrate a degree of “innovation” in their business (for example, the research and development and intellectual property requirements). Additionally, prospective listing applicants under Main Board Listing Rules Chapter 18C and Chapter 18A must also have received meaningful third-party investment before listing with the investor remaining at the initial public offer and/or is subject to share lock-up restrictions. These additional requirements are comparable to the “Innovative Company Requirements” (Chapter 2.2, para 4 of the Guide for New Listing Applicants) and the “external validation requirement” (Chapter 2.2, para 6 of the Guide for New Listing Applicants) imposed by Main Board Listing Rules Chapter 8A that apply to HKEx listing applicants with a WVR structure.

    Accordingly, prospective Specialist Technology Companies and Biotech Companies meeting the listing requirements of Main Board Listing Rules Chapter 18C and Chapter 18A are now presumed to satisfy both the “Innovative Company Requirements” and the “external validation requirement” of Main Board Listing Rules Chapter 8A. Specialist Technology Companies and Biotech Companies that wish to adopt a WVR structure on listing are reminded that all other Main Board Listing Rules Chapter 8A requirements must still be met, including but not limited to those under Chapter 2.2, para 6 of the Guide for New Listing Applicants (i.e. the requirements on the company’s success, the contribution of the beneficiary, and the role of the WVR beneficiary).

    This newsletter is for information purposes only.

    Its contents do not constitute legal advice and it should not be regarded as a substitute for detailed advice in individual cases. Transmission of this information is not intended to create and receipt does not constitute a lawyer-client relationship between Charltons and the user or browser. Charltons is not responsible for any third party content which can be accessed through the website.

    If you do not wish to receive this newsletter please let us know by emailing us at unsubscribe@charltonslaw.com

    Jurisdictional Law Firm of the Year: Hong Kong SAR

    IFLR Asia-Pacific Awards 2024

    Charltons

    Dominion Centre, 12th
    Floor43-59 Queen’s Road East Hong Kong

    Tel: + (852) 2905 7888

    Fax: + (852) 2854 9596

    www.charltonslaw.com

    Charltons – Hong Kong Law – 687– 3 June 2025

     
    Hong Kong’s Company Re-domiciliation Regime effective on 23 May 2025
    • Terms & conditions
    • Privacy
    • Notice
    • Hyperlink policy
    • Site map
    • Contact Us
    ©Copyright Charltons 2025. All rights reserved.
    facebook
    linkedin
    instagram
    youtube
    Spotify for Creators - Charltons Law Podcasts
    rumble